BTZ-043 - Multiple Ascending Dose (MAD) to Evaluate Safety, Tolerability and Early Bactericidal Activity (EBA)
Conditions: Pulmonary Tuberculoses; Other Specified Pulmonary Tuberculosis Interventions: Drug: BTZ-043; Drug: Rifafour e-275®; Drug: Probe Drug Cocktail; Drug: Dolutegravir 50mg Tab Sponsors: Michael Hoelscher; European and Developing Countries Clinical Trials Partnership (EDCTP); Radboud University; German Federal Ministry of Education and Research Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials